ST. LOUIS, Sept. 2, 2011 /PRNewswire/ -- Allied Healthcare
Products, Inc., (NASDAQ: AHPI) reported a profitable fourth quarter
and fiscal year despite sluggish sales to hospitals and government
entities still suffering from recession-driven budget cuts.
Allied announced net income of about $204,000, or 3
cents per basic and diluted share, for the 2011 fiscal year
compared to a loss of about $600,000,
or a negative 7 cents per share, for
the previous year.
For the quarter, Allied increased net income to about
$115,000, or 1
cent per basic and diluted share, from about $86,000, or 1 cent
per share, for the previous year.
Allied sales for the fiscal year ended June 30, 2011, increased by about $750,000, or nearly 2 percent, to about
$46.8 million. Sales for the fourth
quarter increased by almost $434,000,
or 3.5 percent, to about $12.1
million compared to the previous year's fourth quarter.
Allied reduced selling, general and administrative (SG&A)
expenses in the 2011 fiscal year by more than 10 percent, from
about $11.9 million to $10.6 million.
Selling, general and administrative expenses in the prior
year were affected by a non-cash charge of $609,000 for the grant of stock options.
"Domestic sales to hospitals and emergency markets increased
modestly in this fiscal year," said Earl
Refsland, Allied president and chief executive officer. "But
both markets remain significantly below pre-recession levels."
Refsland said that sales in Allied's international markets also
remain well below pre-recession levels.
"Our cost structure is strong, so Allied is well positioned to
take advantage of the markets' return to more normal demand
levels," Refsland said.
Allied ended the 2011 fiscal year with more than $6 million in cash, Refsland said.
Allied Healthcare Products manufactures a variety of respiratory
products used in the healthcare industry in a range of hospital and
alternate care settings including sub-acute facilities, home
healthcare and emergency medical care. Allied product lines include
respiratory care products, medical gas equipment and emergency
medical products. Allied products are marketed to hospitals,
hospital equipment dealers, hospital construction contractors, home
healthcare dealers and emergency medical products dealers.
"SAFE HARBOR" STATEMENT: Statements contained in this release
that are not historical facts or information are "forward-looking
statements." Words such as "believe," "expect," "intend,"
"will," "should," and other expressions that indicate future events
and trends identify such forward-looking statements. These
forward-looking statements involve risks and uncertainties that
could cause the outcome and future results of operations and
financial condition to be materially different than stated or
anticipated based on the forward-looking statements. Such risks and
uncertainties include both general economic risks and
uncertainties, risks and uncertainties affecting the demand for and
economic factors affecting the delivery of health care services,
and specific matters which relate directly to the Company's
operations and properties as discussed in its periodic filings with
the Securities and Exchange Commission. The Company cautions that
any forward-looking statement contained in this report reflects
only the belief of the Company or its management at the time the
statement was made. Although the Company believes such
forward-looking statements are based upon reasonable assumptions,
such assumptions may ultimately prove inaccurate or incomplete. The
Company undertakes no obligation to update any forward-looking
statement to reflect events or circumstances after the date on
which the statement was made.
ALLIED
HEALTHCARE PRODUCTS, INC.
|
|
CONSOLIDATED
STATEMENT OF OPERATIONS
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended,
|
|
Twelve
months ended,
|
|
|
June
30,
|
|
June
30,
|
|
|
2011
|
|
2010
|
|
2011
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
$12,101,826
|
|
$11,668,246
|
|
$46,783,436
|
|
$46,034,248
|
|
Cost of sales
|
9,068,116
|
|
8,772,006
|
|
35,780,657
|
|
34,944,714
|
|
Gross profit
|
3,033,710
|
|
2,896,240
|
|
11,002,779
|
|
11,089,534
|
|
|
|
|
|
|
|
|
|
|
Selling, general and
administrative expenses
|
2,813,753
|
|
2,674,223
|
|
10,593,869
|
|
11,871,758
|
|
Income (loss) from
operations
|
219,957
|
|
222,017
|
|
408,910
|
|
(782,224)
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
(9,041)
|
|
(5,764)
|
|
(32,733)
|
|
(10,168)
|
|
Interest expense
|
-
|
|
1,505
|
|
66
|
|
4,269
|
|
Other, net
|
10,219
|
|
13,599
|
|
78,150
|
|
117,189
|
|
|
1,178
|
|
9,340
|
|
45,483
|
|
111,290
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before provision
for
|
|
|
|
|
|
|
|
|
(benefit from) income
taxes
|
218,779
|
|
212,677
|
|
363,427
|
|
(893,514)
|
|
|
|
|
|
|
|
|
|
|
Provision for (benefit from)
income taxes
|
104,053
|
|
126,412
|
|
159,019
|
|
(293,941)
|
|
Net income (loss)
|
$114,726
|
|
$86,265
|
|
$204,408
|
|
($599,573)
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share -
Basic
|
$0.01
|
|
$0.01
|
|
$0.03
|
|
($0.07)
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share -
Diluted
|
$0.01
|
|
$0.01
|
|
$0.03
|
|
($0.07)
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
outstanding - Basic
|
8,124,386
|
|
8,093,386
|
|
8,107,313
|
|
8,066,740
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
outstanding - Diluted
|
8,136,743
|
|
8,112,373
|
|
8,124,957
|
|
8,066,740
|
|
|
|
|
|
|
|
|
|
ALLIED
HEALTHCARE PRODUCTS, INC.
|
|
CONSOLIDATED
BALANCE SHEET
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
June 30,
2011
|
|
June 30,
2010
|
|
ASSETS
|
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash and cash
equivalents
|
$ 6,512,887
|
|
$ 5,263,324
|
|
|
Accounts receivable, net of
allowances
|
|
|
|
|
|
of $300,000
|
5,366,860
|
|
5,418,253
|
|
|
Inventories, net
|
10,553,289
|
|
11,155,456
|
|
|
Income tax receivable
|
95,578
|
|
877,665
|
|
|
Other current assets
|
213,745
|
|
221,840
|
|
|
Total current
assets
|
22,742,359
|
|
22,936,538
|
|
|
Property, plant and equipment,
net
|
8,660,507
|
|
9,661,395
|
|
|
Other assets, net
|
362,480
|
|
333,084
|
|
|
Total
assets
|
$ 31,765,346
|
|
$ 32,931,017
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS'
EQUITY
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
Accounts payable
|
$ 1,644,910
|
|
$ 1,950,446
|
|
|
Other accrued
liabilities
|
1,645,552
|
|
2,241,259
|
|
|
Deferred income taxes
|
512,572
|
|
429,699
|
|
|
Deferred revenue
|
688,200
|
|
688,200
|
|
|
Total current
liabilities
|
4,491,234
|
|
5,309,604
|
|
|
|
|
|
|
|
Deferred revenue
|
114,700
|
|
802,900
|
|
|
|
|
|
|
|
Commitments and
contingencies
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
Preferred stock; $0.01 par
value; 1,500,000 shares
|
|
|
|
|
|
authorized; no shares
issued and outstanding
|
-
|
|
-
|
|
|
Series A preferred stock; $0.01
par value; 200,000 shares
|
|
|
|
|
|
authorized; no shares
issued and outstanding
|
-
|
|
-
|
|
|
Common stock; $0.01 par value;
30,000,000 shares
|
|
|
|
|
|
authorized; 10,427,878 and
10,396,878 shares issued
|
|
|
|
|
|
at June 30, 2011 and June
30, 2010, respectively;
|
|
|
|
|
|
8,124,386 and 8,093,386
shares outstanding at
|
|
|
|
|
|
June 30, 2011 and June 30,
2010, respectively
|
104,279
|
|
103,969
|
|
|
Additional paid-in
capital
|
48,499,103
|
|
48,362,922
|
|
|
Accumulated deficit
|
(712,542)
|
|
(916,950)
|
|
|
Less treasury stock, at cost;
2,303,492 shares at
|
|
|
|
|
|
June 30, 2011 and June
30, 2010, respectively
|
(20,731,428)
|
|
(20,731,428)
|
|
|
Total stockholders'
equity
|
27,159,412
|
|
26,818,513
|
|
|
Total liabilities
and stockholders' equity
|
$ 31,765,346
|
|
$ 32,931,017
|
|
|
|
|
|
|
SOURCE Allied Healthcare Products, Inc.